Correction to: L1077P CFTR pathogenic variant function rescue by Elexacaftor-Tezacaftor-Ivacaftor in cystic fbrosis patient-derived air-liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients

Affiliations

• ¹ Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
• ² Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
• ³ Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
• ⁴ CEINGEBiotecnologie Avanzate S.c.a.r.l, Naples, Italy.
• ⁵ Confocal Microscopy Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
• ⁶ Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
• ⁷ Fondazione Policlinico Universitario 'A. Gemelli'-IRCCS, Rome, Italy.
• ⁸ Cystic Fibrosis Reference Center of Lazio Region, AOU Policlinico Umberto I, Rome, Italy.
• ⁹ Cenci Bolognetti Foundation, Pasteur Institute, Sapienza University of Rome, Rome, Italy.
• ¹⁰ Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy. adriana.eramo@iss.it.